Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology-Reference-Cited by-同舟云学术

Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology

Published:2022-02-17 Issue:4 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Abedi Elham¹^ORCID,Karimi Mehran¹^ORCID,Yaghobi Ramin²^ORCID,Mohammadi Hamid³^ORCID,Haghpanah Sezaneh¹^ORCID,Moghadam Mohamad¹^ORCID,Bayat Elahe⁴,Rezvani Alireza¹,Ramzi Mani¹^ORCID

Affiliation:

1. Hematology Research Center Shiraz University of Medical Sciences Shiraz Iran

2. Transplant Research Center Shiraz University of Medical Sciences Shiraz Iran

3. Department of Pediatrics, School of Medicine Shiraz University of Medical Sciences Shiraz Iran

4. Department of Biochemistry School of Medicine Shiraz University of Medical Sciences Shiraz Iran

Funder

Shiraz University of Medical Sciences

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24289

Reference46 articles.

1. Molecular diagnostics of myeloproliferative neoplasms

2. Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

3. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome

4. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting

5. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia